Legend Biotech Shares Outstanding 2019-2021 | LEGN

Legend Biotech shares outstanding history from 2019 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Legend Biotech shares outstanding for the quarter ending September 30, 2021 were 0.145B, a 9.68% increase year-over-year.
  • Legend Biotech 2020 shares outstanding were 0.118B, a 18.15% increase from 2019.
  • Legend Biotech 2019 shares outstanding were 0.1B, a 0% decline from 2018.
  • Legend Biotech 2018 shares outstanding were 0.1B, a INF% increase from .
Legend Biotech Annual Shares Outstanding
(Millions of Shares)
2020 118
2019 100
2018 100
Legend Biotech Quarterly Shares Outstanding
(Millions of Shares)
2021-09-30 145
2021-06-30 139
2021-03-31 133
2020-12-31 118
2020-09-30 132
2020-06-30 108
2020-03-31 100
2019-12-31 100
2019-09-30 100
2019-06-30 100
2019-03-31 104
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.389B $0.076B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69